DE60333680D1 - VERFAHREN ZUR IN-VITRO-ERKENNUNG VON ANORMALER Magen-DYSPLASIE - Google Patents

VERFAHREN ZUR IN-VITRO-ERKENNUNG VON ANORMALER Magen-DYSPLASIE

Info

Publication number
DE60333680D1
DE60333680D1 DE60333680T DE60333680T DE60333680D1 DE 60333680 D1 DE60333680 D1 DE 60333680D1 DE 60333680 T DE60333680 T DE 60333680T DE 60333680 T DE60333680 T DE 60333680T DE 60333680 D1 DE60333680 D1 DE 60333680D1
Authority
DE
Germany
Prior art keywords
dysplasia
vitro detection
anormal
stomach
methylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60333680T
Other languages
English (en)
Inventor
Hua Bai
Yu Sun
Jing Zhou
Jiyu Li
Dajun Deng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING INST CANCER RES
Beijing Institute for Cancer Research
Original Assignee
BEIJING INST CANCER RES
Beijing Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING INST CANCER RES, Beijing Institute for Cancer Research filed Critical BEIJING INST CANCER RES
Application granted granted Critical
Publication of DE60333680D1 publication Critical patent/DE60333680D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
DE60333680T 2003-03-13 2003-03-13 VERFAHREN ZUR IN-VITRO-ERKENNUNG VON ANORMALER Magen-DYSPLASIE Expired - Lifetime DE60333680D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2003/000180 WO2004081232A1 (en) 2003-03-13 2003-03-13 The method of in vitro detecting aberrant dysplasia, and the artificial nucleotides being used

Publications (1)

Publication Number Publication Date
DE60333680D1 true DE60333680D1 (de) 2010-09-16

Family

ID=32968446

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60333680T Expired - Lifetime DE60333680D1 (de) 2003-03-13 2003-03-13 VERFAHREN ZUR IN-VITRO-ERKENNUNG VON ANORMALER Magen-DYSPLASIE

Country Status (7)

Country Link
US (1) US20060252043A1 (de)
EP (1) EP1602731B1 (de)
CN (1) CN100344771C (de)
AT (1) ATE476522T1 (de)
AU (1) AU2003221217A1 (de)
DE (1) DE60333680D1 (de)
WO (1) WO2004081232A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9416423B2 (en) * 2011-01-11 2016-08-16 Beijing Institute For Cancer Research Primer group for detecting CPG island methylation of P16 gene using methylation-specific fluorescence technique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor
DE19959691A1 (de) * 1999-12-06 2001-08-16 Epigenomics Ag Verfahren zur parallelen Detektions des Methylierungszustandes von genomischer DNA
GB9929720D0 (en) * 1999-12-17 2000-02-09 Zeneca Ltd Diagnostic method
WO2002018649A1 (en) * 2000-08-25 2002-03-07 Lovelace Respiratory Research Institute Nested methylation-specific polymerase chain reaction cancer detection method
DE10139283A1 (de) * 2001-08-09 2003-03-13 Epigenomics Ag Verfahren und Nukleinsäuren zur Analyse von Colon-Krebs

Also Published As

Publication number Publication date
EP1602731A4 (de) 2006-08-09
AU2003221217A1 (en) 2004-09-30
EP1602731B1 (de) 2010-08-04
EP1602731A1 (de) 2005-12-07
ATE476522T1 (de) 2010-08-15
US20060252043A1 (en) 2006-11-09
CN1759188A (zh) 2006-04-12
CN100344771C (zh) 2007-10-24
WO2004081232A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
DE60029092D1 (de) Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
EP2339022A3 (de) Verwendung methylierter oder unmethylierter line-1-dna als krebsmarker
ES2575697T3 (es) Métodos y sondas para detectar cáncer de esófago
EP1721992A3 (de) Verfahren und Nukleinsäuren für die Analyse von zellulären Proliferationsstörungen
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
ATE403755T1 (de) Identifizierung einer erbb2- genexpressionssignatur bei brustkrebs
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
ATE502048T1 (de) Fluoreszentes chlorotoxinkonjugat und verfahren zur intraoperativen sichtbarmachung von krebs
MXPA05008519A (es) Forma de algodon mon 88913 y composiciones y metodos para detectarla.
ATE476908T1 (de) System und diagnoseverfahren zur optischen detektion von verdächtigen stellen einer gewebeprobe
ATE473296T1 (de) Verfahren zum nachweis abnormal methylierter nukleinsäure in heterogenen biologischen proben
WO2004097051A3 (en) Methods for diagnosing aml and mds differential gene expression
EP2386859A3 (de) Diagnostische Tumormarker
WO2006034879A3 (en) Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders
EP2484778A3 (de) Verfahren und Nukleinsäuren zur Detektion kolorektaler proliferativer Zellerkrankungen
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
CA2531451A1 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO2008008983A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
ATE235560T1 (de) Diagnostisches verfahren basierend auf der quantifizierung extramitochondrialer dna
DE60333680D1 (de) VERFAHREN ZUR IN-VITRO-ERKENNUNG VON ANORMALER Magen-DYSPLASIE
WO2008104984A3 (en) Diagnosis and prognosis of various types of cancers
DE602004030910D1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
EP2226638A3 (de) In-vitro-Verfahren zum Screening zugänglicher biologischer Marker in pathologischen Geweben
ATE486964T1 (de) Molekulares verfahren zur diagnose von prostatakrebs